Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Jumpstarting advance care planning for Alaska Native and American Indian adults

Official title: Jumpstarting Advance Care Planning With ANAI People in Primary Care

Run by Southcentral Foundation · NCT06538493 · Data updated 2026-11-12

This project will test a culturally tailored program called JUMPSTART-ANAI to see if it helps Alaska Native and American Indian adults with serious illness start advance care planning conversations with their primary care providers.

More Advance Care Planning trials

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment400 (estimated)
SponsorSouthcentral Foundation
Academic / other
Locations1 site (Anchorage, Alaska)
StatusRecruiting
StartedApril 1, 2025
Main results expectedDecember 30, 2026
Study endsMay 30, 2027
Registry record updatedJuly 9, 2026
Trial IDNCT06538493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Alaska Native and/or American Indian adults aged 40 or older, empaneled to a Southcentral Foundation primary care provider, with at least one serious illness, no documented advance directive, and able to complete a 30-minute visit.

Probably not a fit

Patients who already have an advance directive, those with cognitive impairment that prevents participation, or people not empaneled to Southcentral Foundation are unlikely to benefit from enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

JUMPSTART-ANAI is a culturally tailored advance care planning communication intervention being compared with usual care in a cluster randomized, hybrid type 1 effectiveness-implementation trial within a Tribal primary care system. The primary outcome is documentation of advance directives in the electronic health record as a marker of patient-driven ACP conversations. The trial enrolls Alaska Native and/or American Indian adults aged 40 or older with at least one serious illness who are empaneled to Southcentral Foundation and do not already have an advance directive. Investigators will also identify clinic- and system-level factors that affect successful implementation of JUMPSTART-ANAI across primary care settings.

Why it matters

Potential benefit: If successful, more ANAI patients with serious illness may have their care preferences recorded and receive medical care that better matches their values and goals.

How similar studies have gone: A prior pilot of JUMPSTART-ANAI among 68 ANAI adults showed feasibility and informed this larger trial, but large-scale effectiveness and implementation in a cluster randomized design remain untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age 40 or older with a qualifying serious illness condition (e.g., COPD) OR Age 65 or older (regardless of diagnosis) AND Alaska Native and/or American Indian AND Empaneled to a primary care provider AND 2 or more to primary care in last 12 months AND No advance directives documented in electronic health record

Exclusion Criteria:

Unable to provide informed consent AND/OR Not able to complete 30-minute study visit by phone, video call, or in person

Where it's running

  • Southcentral Foundation
    Anchorage, Alaska, United States
    Recruiting

Study contacts

  • Principal investigator: Jennifer Shaw, PhD — University of Alaska Fairbanks
  • Study coordinator: Shannon Medlock, MS
  • Email: smedlock@scf.cc
  • Phone: (907)729-6322

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.